{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_20708", "batch_size": 200, "batch_pos": 64, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral/procedural language without high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_6164", "batch_size": 200, "batch_pos": 54, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses future testing but does not use a moderate verb paired with scale or impact.", "method": "llm_batch", "batch_id": "batch_3_4584", "batch_size": 200, "batch_pos": 25, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_5764", "batch_size": 200, "batch_pos": 22, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports on the timeline for vaccine testing but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_15052", "batch_size": 200, "batch_pos": 21, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser token ('only', 'just', 'merely', etc.) combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_10636", "batch_size": 200, "batch_pos": 3, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_5336", "batch_size": 200, "batch_pos": 187, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment mentions 'late-stage testing would begin' which describes a future action part of development/capability without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_19536", "batch_size": 200, "batch_pos": 108, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
